EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Newborn Screening for Isovaleric Acidemia: Treatment With Pivalate‐Generating Antibiotics Contributed to False C5 ‐Carnitine Positivity in a Chinese Population

Wei Zhou iD, Ting Huang, Huizhong Li, Maosheng Gu

Molecular Genetics & Genomic Medicine · 2024

DOI: 10.1002/mgg3.70034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2024. Verfasst von Wei Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Neonatal Screening Center, Xuzhou Maternity and Child Health Care Hospital, Xuzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Carnitine, Neonatal Screening, Anti-Bacterial Agents, Amino Acid Metabolism, Inborn Errors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Jiangsu Province Maternal and Child Health Project, Technology Innovation Project of Xuzhou commission of Xuzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Newborn screening (NBS) for isovaleric acidemia (IVA) is implemented via tandem mass spectrometry (MS/MS), but false‐positive results are still common. In addition, NBS for IVA is limited by a lack of suitable biomarkers, especially after the use of pivaloylester‐containing antibiotics.

Methods

We conducted a retrospective cohort study to explore the clinical correlation between antibiotic administration and false‐positive results for isovalerylcarnitine (C5).

Results

A total of 509,313 newborns were recruited from the initial NBS study, only one of whom underwent genetic confirmation, conducted between 2015 and 2020. Significant associations between false‐positive C5‐carnitine screening results and treatment with pivalate‐generating antibiotics were identified with retrospective analysis.

Conclusions

The current results highlight the detrimental effects of false‐positive C5‐carnitine screening results. Unless the licensing of pivalate‐generating antibiotics for use during the neonatal period is reconsidered, a second‐tier test for C5 determination will be necessary.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarnitineNeonatal ScreeningAnti-Bacterial AgentsAmino Acid Metabolism, Inborn ErrorsIsovaleryl-CoA DehydrogenaseHumansInfant, NewbornFalse Positive ReactionsFemaleMaleRetrospective StudiesChinaPentanoic AcidsEast Asian People

Stichwörter der Autor:innen

isovaleric acidemiapivalate‐generating antibioticssecond‐tier screening

Substanzen

CarnitineAnti-Bacterial AgentsIsovaleryl-CoA DehydrogenasePentanoic Acids

Autor:innen und Institutionen

  • Neonatal Screening Center, Xuzhou Maternity and Child Health Care Hospital, Xuzhou, Jiangsu, China.
  • Department of Pharmacy, Xuzhou Maternity and Child Health Care Hospital, Xuzhou, Jiangsu, China.

ORCID-Profile: Wei Zhou

Förderung

  • Jiangsu Province Maternal and Child Health Project
  • Technology Innovation Project of Xuzhou commission of Xuzhou

Zitieren

APA

Zhou, W., Huang, T., Li, H., & Gu, M. (2024). Newborn Screening for Isovaleric Acidemia: Treatment With Pivalate‐Generating Antibiotics Contributed to False C5 ‐Carnitine Positivity in a Chinese Population. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70034

Vancouver

Zhou W, Huang T, Li H, Gu M. Newborn Screening for Isovaleric Acidemia: Treatment With Pivalate‐Generating Antibiotics Contributed to False C5 ‐Carnitine Positivity in a Chinese Population. Molecular Genetics & Genomic Medicine. 2024. doi:10.1002/mgg3.70034

BibTeX
@article{Zhou2024,
  author = {Zhou, Wei and Huang, Ting and Li, Huizhong and Gu, Maosheng},
  title = {Newborn Screening for Isovaleric Acidemia: Treatment With Pivalate‐Generating Antibiotics Contributed to False C5 ‐Carnitine Positivity in a Chinese Population},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2024},
  doi = {10.1002/mgg3.70034}
}
Kostenlos starten →